BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. (BMRN) Stock Overview
Explore BioMarin Pharmaceutical Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
12.1B
P/E Ratio
456.36
EPS (TTM)
$2.69
ROE
0.00%
BMRN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of BioMarin Pharmaceutical Inc. (BMRN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 74.42, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $39.23.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 456.36 and a market capitalization of 12.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.